Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes early vascularization of implanted porous polyethylene (Medpor®)

Acta Biomaterialia

Volumn 10, Issue 11, 2014, Pages 4661-4669

  Laschke, M W ^a   Augustin, V ^a   Kleer, S ^a   Tschernig, T ^a   Menger, M D ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Dorsal skinfold chamber; Incorporation; MALP 2; Polyethylene; Vascularization

Indexed keywords

BLOOD VESSELS; CHEMICAL ACTIVATION; FLUORESCENCE MICROSCOPY; POLYETHYLENES; TISSUE;

CRANIOFACIAL; DORSAL SKINFOLD CHAMBERS; HOST TISSUES; INCORPORATION; LIPOPEPTIDES; MACROPHAGE-ACTIVATING LIPOPEPTIDE-2; PROPERTY; RECONSTRUCTIVE SURGERY; TOLL-LIKE RECEPTOR 2; VASCULARIZATION;

MACROPHAGES;

MACROPHAGE ACTIVATING LIPOPEPTIDE 2; POLYETHYLENE; POROUS POLYETHYLENE; UNCLASSIFIED DRUG; BIOMATERIAL; LIPOPEPTIDE; LOWER EYELID SPACER; MACROPHAGE STIMULATORY LIPOPEPTIDE 2; POLYETHYLENE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FOREIGN BODY REACTION; GRANULATION TISSUE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MOUSE; NONHUMAN; SKINFOLD; VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD FLOW; DRUG EFFECTS; PATHOLOGY; POROSITY; PROSTHESES AND ORTHOSES;

ANIMALS; BIOCOMPATIBLE MATERIALS; GRANULATION TISSUE; LEUKOCYTES; LIPOPEPTIDES; MALE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENES; POROSITY; PROSTHESES AND IMPLANTS; REGIONAL BLOOD FLOW;

EID: 84908125671     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.07.004     Document Type: Article

References (35)

1. I. Niechajev Facial reconstruction using porous high-density polyethylene (Medpor): long-term results Aesthetic Plast Surg 36 2012 917 927
2. M.J. Yaremchuk Facial skeletal reconstruction using porous polyethylene implants Plast Reconstr Surg 111 2003 1818 1827
3. M.N. Naik, R.K. Murthy, and S.G. Honavar Comparison of vascularization of Medpor and Medpor-Plus orbital implants: a prospective, randomized study Ophthal Plast Reconstr Surg 23 2007 463 467
4. S.K. Jung, W.K. Cho, J.S. Paik, and S.W. Yang Long-term surgical outcomes of porous polyethylene orbital implants: a review of 314 cases Br J Ophthalmol 96 2012 494 498
5. A.A. Winkler, Z.M. Soler, P.L. Leong, A. Murphy, T.D. Wang, and T.A. Cook Complications associated with alloplastic implants in rhinoplasty Arch Facial Plast Surg 14 2012 437 441
6. A.P. Sclafani, J.R. Thomas, A.J. Cox, and M.H. Cooper Clinical and histologic response of subcutaneous expanded polytetrafluoroethylene (Gore-Tex) and porous high-density polyethylene (Medpor) implants to acute and early infection Arch Otolaryngol Head Neck Surg 123 1997 328 336
7. S. Ehrmantraut, M.W. Laschke, D. Merkel, C. Scheuer, V. Willnecker, and A. Meyer-Lindenberg Perioperative steroid administration inhibits angiogenic host tissue response to porous polyethylene (Medpor) implants Eur Cell Mater 19 2010 107 116
8. A. Naumann, S. Ehrmantraut, V. Willnecker, M.D. Menger, B. Schick, and M.W. Laschke Ear reconstruction using porous polyethylene implants. Effect of cortisone on edema reduction and healing process HNO 59 2011 268 273
9. S. Strieth, T. Weger, C. Bartesch, P. Bittmann, K. Stelter, and A. Berghaus Biocompatibility of porous polyethylene implants tissue-engineered by extracellular matrix and VEGF J Biomed Mater Res A 93 2010 1566 1573
10. S. Ehrmantraut, A. Naumann, V. Willnecker, S. Akinyemi, C. Körbel, and C. Scheuer Vitalization of porous polyethylene (Medpor®) with chondrocytes promotes early implant vascularization and incorporation into the host tissue Tissue Eng A 18 2012 1562 1572
11. P.F. Mühlradt, M. Kiess, H. Meyer, R. Süssmuth, and G. Jung Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration J Exp Med 185 1997 1951 1958
12. F. Rharbaoui, B. Drabner, S. Borsutzky, U. Winckler, M. Morr, and B. Ensoli The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant Eur J Immunol 32 2002 2857 2865
13. A. Lührmann, T. Tschernig, R. Pabst, and S. Niewiesk Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2 Vaccine 23 2005 4721 4726
14. U. Deiters, M. Gumenscheimer, C. Galanos, and P.F. Mühlradt Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses Infect Immun 71 2003 4456 4462
15. C. Schneider, T. Schmidt, C. Ziske, K. Tiemann, K.M. Lee, and V. Uhlinsky Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model Gut 53 2004 355 361
16. J. Schmidt, T. Welsch, D. Jäger, P.F. Mühlradt, M.W. Büchler, and A. Märten Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial Br J Cancer 97 2007 598 604
17. U. Deiters, J. Barsig, B. Tawil, and P.F. Mühlradt The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice Exp Dermatol 13 2004 731 739
18. M. Niebuhr, P.F. Mühlradt, M. Wittmann, A. Kapp, and T. Werfel Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice-a phase I trial in 12 patients Exp Dermatol 17 2008 1052 1056
19. K. Grote, K. Sonnenschein, P.R. Kapopara, A. Hillmer, C. Grothusen, and G. Salguero Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury Arterioscler Thromb Vasc Biol 33 2013 2097 2104
20. K. Grote, H. Schuett, G. Salguero, C. Grothusen, J. Jagielska, and H. Drexler Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration Blood 115 2010 2543 2552
21. K. Grote, M. Petri, C. Liu, P. Jehn, S. Spalthoff, and H. Kokemüller Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors Eur Cell Mater 26 2013 66 79
22. M.W. Laschke, B. Vollmar, and M.D. Menger The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue Eur Cell Mater 22 2011 147 164
23. M.W. Laschke, J.M. Häufel, C. Scheuer, and M.D. Menger Angiogenic and inflammatory host response to surgical meshes of different mesh architecture and polymer composition J Biomed Mater Res B Appl Biomater 91 2009 497 507
24. A.S. De Vriese, T.J. Verbeuren, M.O. Vallez, N.H. Lameire, M. De Buyzere, and P.M. Vanhoutte Off-line analysis of red blood cell velocity in renal arterioles J Vasc Res 37 2000 26 31
25. M. Baker, and H. Wayland On-line volume flow rate and velocity profile measurement for blood in microvessels Microvasc Res 7 1974 131 143
26. M.W. Laschke, S. Kleer, C. Scheuer, S. Schuler, P. Garcia, and D. Eglin Vascularisation of porous scaffolds is improved by incorporation of adipose tissue-derived microvascular fragments Eur Cell Mater 24 2012 266 277
27. M. Rücker, M.W. Laschke, D. Junker, C. Carvalho, A. Schramm, and R. Mülhaupt Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice Biomaterials 27 2006 5027 5038
28. K. Merritt, J.W. Shafer, and S.A. Brown Implant site infection rates with porous and dense materials J Biomed Mater Res 13 1979 101 108
29. K. Stelter, S. Strieth, and A. Berghaus Porous polyethylene implants in revision rhinoplasty: chances and risks Rhinology 45 2007 325 331
30. M.W. Laschke, Y. Harder, M. Amon, I. Martin, J. Farhadi, and A. Ring Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes Tissue Eng 12 2006 2093 2104
31. P. Jeanmonod, M.W. Laschke, N. Gola, M. von Heesen, M. Glanemann, and S. Dold Silver acetate coating promotes early vascularization of Dacron vascular grafts without inducing host tissue inflammation J Vasc Surg 58 2013 1637 1643
32. M.W. Laschke, M. Rücker, G. Jensen, C. Carvalho, R. Mülhaupt, and N.C. Gellrich Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds J Biomed Mater Res A 85 2008 397 407
33. J.M. Anderson, A. Rodriguez, and D.T. Chang Foreign body reaction to biomaterials Semin Immunol 20 2008 86 100
34. G.C. Gurtner, S. Werner, Y. Barrandon, and M.T. Longaker Wound repair and regeneration Nature 453 2008 314 321
35. K. Reppe, T. Tschernig, A. Lührmann, V. van Laak, K. Grote, and M.V. Zemlin Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia Am J Respir Cell Mol Biol 40 2009 474 481